Items Tagged ‘idiopathic pulmonary fibrosis’
June 15, 2021 · Leave a Comment
Transforming medicine for patients with respiratory diseases
The Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery provides a unique service for Mayo Clinic. Embedded in the medical practice, its objective is to transform the practice of medicine – from the inside out. Center researchers work within multidisciplinary teams to identify areas for improvement within […]
View full entry Comment on this
Tags: Aahd Kubbara, acute respiratory illness, Alanna Chamberlain, Andrew Limper, Ann Vu, antifungal, biomedical research, Cassie Kennedy, Center for the Science of Health Care Delivery, chronic obstructive pulmonary disease, COPD, COVID-19
February 8, 2021 · Leave a Comment
Mayo Clinic Research in the news — 2/8/2021
In the week’s news, you can find expertise from Mayo Clinic clinicians and researchers on a range of topics, including several different heart conditions, a blood test for Alzheimer’s, cancer, disparities in diabetes care, and of course COVID-19. Expertise from a Mayo Clinic International consultant is also highlighted, along with Michael Camilleri, M.D., who received […]
View full entry Comment on this
Tags: Alzheimer's disease, artificial intelligence, Bart Demaerschalk, blood cancer, blood disease, blood test, breast cancer, cardiology, cardiovascular disease, caregivers, Center for Digital Health, Center for the Science of Health Care Delivery
September 20, 2019 · Leave a Comment
Good news about the effectiveness of antifibrotics for IPF
In a recent study published in the American Journal of Respiratory and Critical Care, a research team led by Andrew Limper, M.D., a pulmonology and critical care physician at Mayo Clinic, evaluated the effectiveness of pirfenidone and nintedanib for patients with idiopathic pulmonary fibrosis. The researchers reported “the medications had an association with a reduced […]
View full entry Comment on this
Tags: Andrew Limper, Center for the Science of Health Care Delivery, clinical trials, idiopathic pulmonary fibrosis, OptumLabs